Proficio Capital Partners LLC Makes New $5.64 Million Investment in DaVita Inc. (NYSE:DVA)

Proficio Capital Partners LLC bought a new position in DaVita Inc. (NYSE:DVA) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 37,687 shares of the company’s stock, valued at approximately $5,636,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DVA. Franklin Resources Inc. grew its holdings in shares of DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares during the period. FMR LLC boosted its holdings in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares during the period. Atom Investors LP purchased a new position in DaVita during the 3rd quarter valued at about $4,094,000. Assenagon Asset Management S.A. boosted its holdings in DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after acquiring an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management purchased a new position in DaVita during the 3rd quarter valued at about $726,000. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Trading Up 1.7 %

DVA opened at $143.56 on Monday. The firm has a market cap of $11.48 billion, a price-to-earnings ratio of 13.37, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The business’s 50 day moving average is $158.92 and its two-hundred day moving average is $157.65. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Barclays raised their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.